<DOC>
	<DOCNO>NCT02285218</DOCNO>
	<brief_summary>To investigate predictive role adipokines hepatokines detect non-alcoholic fatty liver disease ( NAFLD ) , diabetes , dyslipidmia . To examine association effect clinical biochemical factor ( lab result medication , etc . ) serum level adipokines hepatokines certain subject non-alcoholic fatty liver disease ( NAFLD ) , diabetes , dyslipidmia .</brief_summary>
	<brief_title>Role New Adipokines Hepatokines Prediction Patients With Metabolic Syndrome NAFLD</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>1. dyslipidemia 1. serum triglyceride≥150mg/dl , take medication low triglyceride level ( e.g . fibrates , niacin , omega3 , etc . ) 2. serum LDLC≥100mg/dl , take medication low LDLC level ( e.g . statin , ezetimibe , etc . ) 2. type 2 diabetes 1. define accord ADA guideline ( DM definition ) 2. take antidiabetic medication 3. nonalcoholic fatty liver disease ( NAFLD ) 1. diagnosed fatty liver ultrasonogram 2. diagnosed fatty liver transient elastogram ( Fibroscan ) 3. diagnosed fatty liver abdomina CT scan 4 . Normal control 1. include group 2. take medication relate diabetes dyslipidemia 3 . BMI &lt; 25kg/m2 1. subject refuse agree inform consent 2. subject organtransplantation 3. serum creatinine ≥1.5mg/dl 4. pregnant woman 5. liver cancer pancreatic cancer 6. subject chronic hepatitis B C virus infection 7. NAFLD group , subject excessive alcohol consumption ( men : ≥210g alcohol per week , woman : ≥140g alcohol per week )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>